Global Indemnity Group, LLC quarterly report, Q2 FY2020

Global Indemnity Limited — Q2 2020 Form 10-Q

Reporting period: Quarter and six months ended June 30, 2020. The filing is by Global Indemnity Limited, then a Cayman Islands company; it describes a proposed redomestication under which Global Indemnity Group, LLC would become the publicly listed parent. Unless stated otherwise, dollar amounts below are in millions.

Financial performance and position

MetricQ2 2020Q2 2019Six months 2020Six months 2019
Net earned premiums$141.8$128.2$286.3$250.3
Total revenues$178.8$146.1$265.4$286.3
Net income (loss)$37.6$14.7$(7.0)$34.3
Net income (loss) per diluted share$2.61$1.02$(0.49)$2.39
Operating cash flowNot presented quarterlyNot presented quarterly$52.4$(3.1)

Q2 total revenue and earnings benefited from $38.5 million of net realized investment gains, compared with $3.6 million a year earlier. Net investment income was a loss of $2.4 million, including a $12.0 million loss from alternative investments. For the first half, net realized investment losses were $29.7 million and net investment income was $7.8 million.

Underwriting improved: the consolidated combined ratio was 85.2% in Q2 versus 94.0% in Q2 2019, and 89.0% for the first half versus 91.4%. Underwriting income was $21.7 million in Q2 and $32.3 million in the first half. These results include favorable prior-year reserve development; see material items below.

At June 30, 2020, total assets were $2,113.1 million, investments $1,535.8 million, cash and cash equivalents $76.4 million, total liabilities $1,378.0 million and shareholders’ equity $735.2 million. Debt was $297.7 million, including a $74.6 million margin borrowing facility and subordinated notes due 2045 and 2047. The filing reports $400.2 million of assets on deposit, held in trust or pledged as collateral.

Changes versus comparable periods

  • Q2 gross written premiums fell 8.2% to $164.5 million; first-half gross written premiums were nearly flat at $320.3 million, down 0.4%. First-half net written premiums rose 1.4%, while net earned premiums increased 14.4%.
  • Premium trends varied by segment: first-half Commercial Specialty gross written premiums rose 19.0%; Specialty Property fell 15.0%; Farm, Ranch & Stable rose 2.0%; and Reinsurance Operations fell 32.3%. Management attributed declines mainly to reducing catastrophe-exposed or inadequately profitable business and not renewing property catastrophe treaties, partly offset by Commercial Specialty growth, pricing and new programs.
  • First-half net income shifted to a $7.0 million loss from $34.3 million profit, chiefly reflecting investment losses. Q2 net income increased year over year, helped by realized investment gains.
  • Cash increased to $76.4 million from $44.3 million at year-end 2019. Shareholders’ equity increased to $735.2 million from $726.8 million, including higher accumulated other comprehensive income.

Outlook, management commentary and risks

  • COVID-19: Management said effects were difficult to evaluate and could continue indefinitely. Risks include reduced premium volume, delayed or unpaid premiums, increased claims, investment-market volatility, realized losses and reduced investment liquidity. Legislation requiring business-interruption coverage notwithstanding policy terms or virus exclusions could increase exposure. No quantified COVID-19 loss estimate or formal earnings guidance is provided.
  • Reserves and catastrophe experience: The company recorded $19.9 million of favorable prior-accident-year reserve development in the first half, primarily in Commercial Specialty and Specialty Property. Current-year catastrophe losses were higher than in the prior-year period; the consolidated first-half current accident-year loss ratio rose to 50.6% from 51.3% overall only after favorable development lowered the calendar-year ratio. Reserve estimates remain sensitive to claim frequency and severity.
  • Segment performance: Farm, Ranch & Stable reported a 110.6% Q2 combined ratio and a 101.5% first-half ratio, despite improvement year over year. Commercial Specialty’s Q2 combined ratio improved to 79.4%, in part reflecting favorable reserve development. Reinsurance’s premium mix shifted toward casualty business, which management said has a higher expected loss ratio than property.
  • Investments: Management cited disruption in global markets as a driver of realized gains and losses and alternative-investment volatility. The fixed-income portfolio had an AA- average rating and 4.2-year duration; its embedded book yield was 2.5%, down from 3.0% a year earlier. No credit-loss allowance was recorded on available-for-sale fixed maturities at June 30.
  • Capital actions: In July, the company elected to redeem the full $100 million principal amount of its 7.75% subordinated notes due 2045 on August 15, 2020, plus accrued interest. It also planned to pay the $74.6 million margin facility balance down to zero in August. The board declared $0.25 per share dividends in each of Q1 and Q2; $7.1 million was paid in the first half.
  • Redomestication: The proposed move to the United States required shareholder and regulatory approval; the company anticipated closing around August 28, 2020 if approved and expected no material financial-position impact. The filing notes increased corporate legal and professional expenses associated with the proposal. Fox Paine, the controlling shareholder group, held about 77.5% of voting power; any redomestication advisory fee would be accrued upon consummation, with no amount specified in this filing.
  • Other exposures: The company had $31.2 million in future funding commitments to alternative investments. It described ordinary-course litigation and greater potential for disputes with reinsurers in runoff, but did not expect currently pending proceedings to have a material adverse effect. U.S. insurer dividends are subject to regulatory limits; the U.S. insurance subsidiaries paid no dividends in the first half. The company reported no off-balance-sheet arrangements.

Most important facts for investors to verify

  • Whether the Q2 profit is sustainable apart from investment gains, given the first-half investment loss and volatile alternative-investment results.
  • COVID-19-related claim, premium-collection and investment impacts, including any business-interruption legislation or disputes over policy exclusions.
  • Whether favorable reserve development continues and how current-year catastrophe experience affects ultimate losses and combined ratios.
  • Completion and funding of the planned $100 million note redemption and margin-facility repayment, and resulting cash, debt and liquidity levels.
  • Shareholder and regulatory approval and completion of the proposed redomestication, including any advisory fee and the effects of moving the reinsurance business into U.S. subsidiaries.
  • Progress on the $31.2 million alternative-investment funding commitments and potential losses or liquidity constraints in those investments.